Aminologics Co.Ltd (074430) — Capital Reinvestment Ratio
Aminologics Co.Ltd (074430) has a Capital Reinvestment Ratio of 0.01x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩4.62 Billion) in capital expenditures (₩30.00 Million). Check 074430 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Aminologics Co.Ltd Capital Reinvestment Ratio (2008–2025)
This chart tracks Aminologics Co.Ltd's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Aminologics Co.Ltd.
Annual Capital Reinvestment Ratio for Aminologics Co.Ltd (2008–2025)
Year-by-year Capital Reinvestment Ratio for Aminologics Co.Ltd from 2008 to 2025. See Aminologics Co.Ltd (074430) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | ₩2.54 Billion | ₩45.70 Million | ▼ -73.7% |
| 2024 | 0.07x | ₩7.47 Billion | ₩511.50 Million | ▼ -28.8% |
| 2022 | 0.10x | ₩5.23 Billion | ₩503.20 Million | ▼ -82.5% |
| 2021 | 0.55x | ₩935.52 Million | ₩515.71 Million | ▲ +215.8% |
| 2020 | 0.17x | ₩1.77 Billion | ₩308.67 Million | ▲ +529.1% |
| 2019 | 0.03x | ₩3.60 Billion | ₩100.00 Million | ▼ -45.2% |
| 2018 | 0.05x | ₩4.56 Billion | ₩230.93 Million | ▼ -25.6% |
| 2017 | 0.07x | ₩3.00 Billion | ₩204.29 Million | ▼ -75.3% |
| 2016 | 0.28x | ₩4.14 Billion | ₩1.14 Billion | ▼ -46.2% |
| 2015 | 0.51x | ₩1.93 Billion | ₩989.18 Million | ▲ +28.9% |
| 2008 | 0.40x | ₩12.19 Billion | ₩4.85 Billion | — |